Atlas Trials

Bioequivalence Study of Ibuprofen 200 mg/5 mL Oral Suspension vs. MOMENT 200 mg Coated Tablet

Clinical trial NCT02902289 · COMPLETED

Trial details

NCT number
NCT02902289
Sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2016-06-01
Primary completion
2016-07-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.